BeOne Medicines Ltd. American Depositary Shares ONC
HEALTHCARE · BIOTECHNOLOGYi
Market dataready · fetched 2026-11-04T02:47:02.290Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T21:32:58.014914464Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-04T02:47:01.831791+00:00
BeOne Medicines Ltd. American Depositary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 388.82 | 46.2% | 10.6% | 328.62 | 46.0% | 8.6% |
| 25Δ | 382.47 | 46.2% | 9.2% | 333.95 | 46.3% | 7.5% |
| 30Δ | 376.80 | 46.3% | 8.0% | 339.08 | 46.4% | 6.5% |
| 35Δ | 371.56 | 46.3% | 6.9% | 343.80 | 46.5% | 5.7% |
| 40Δ | 366.70 | 46.3% | 6.0% | 348.43 | 46.5% | 4.9% |
| 45Δ | 362.00 | 46.3% | 5.2% | 352.95 | 46.4% | 4.2% |
| 50Δ | 357.44 | 46.2% | 4.5% | 357.41 | 46.2% | 3.6% |
| 55Δ | 352.97 | 46.2% | 3.8% | 361.94 | 46.0% | 3.0% |
| 60Δ | 348.43 | 46.3% | 3.2% | 366.55 | 45.9% | 2.5% |
| 65Δ | 343.72 | 46.7% | 2.7% | 371.35 | 45.8% | 2.0% |
| 70Δ | 338.96 | 46.8% | 2.2% | 376.71 | 46.0% | 1.6% |
| 75Δ | 334.01 | 46.2% | 1.8% | 382.42 | 46.1% | 1.2% |
| 80Δ | 328.87 | 45.6% | 1.3% | 388.68 | 46.0% | 0.9% |
20Δ
- Pseudo strike
- 388.82
- IV
- 46.2%
- B/E move
- 10.6%
- Pseudo strike
- 328.62
- IV
- 46.0%
- B/E move
- 8.6%
25Δ
- Pseudo strike
- 382.47
- IV
- 46.2%
- B/E move
- 9.2%
- Pseudo strike
- 333.95
- IV
- 46.3%
- B/E move
- 7.5%
30Δ
- Pseudo strike
- 376.80
- IV
- 46.3%
- B/E move
- 8.0%
- Pseudo strike
- 339.08
- IV
- 46.4%
- B/E move
- 6.5%
35Δ
- Pseudo strike
- 371.56
- IV
- 46.3%
- B/E move
- 6.9%
- Pseudo strike
- 343.80
- IV
- 46.5%
- B/E move
- 5.7%
40Δ
- Pseudo strike
- 366.70
- IV
- 46.3%
- B/E move
- 6.0%
- Pseudo strike
- 348.43
- IV
- 46.5%
- B/E move
- 4.9%
45Δ
- Pseudo strike
- 362.00
- IV
- 46.3%
- B/E move
- 5.2%
- Pseudo strike
- 352.95
- IV
- 46.4%
- B/E move
- 4.2%
50Δ
- Pseudo strike
- 357.44
- IV
- 46.2%
- B/E move
- 4.5%
- Pseudo strike
- 357.41
- IV
- 46.2%
- B/E move
- 3.6%
55Δ
- Pseudo strike
- 352.97
- IV
- 46.2%
- B/E move
- 3.8%
- Pseudo strike
- 361.94
- IV
- 46.0%
- B/E move
- 3.0%
60Δ
- Pseudo strike
- 348.43
- IV
- 46.3%
- B/E move
- 3.2%
- Pseudo strike
- 366.55
- IV
- 45.9%
- B/E move
- 2.5%
65Δ
- Pseudo strike
- 343.72
- IV
- 46.7%
- B/E move
- 2.7%
- Pseudo strike
- 371.35
- IV
- 45.8%
- B/E move
- 2.0%
70Δ
- Pseudo strike
- 338.96
- IV
- 46.8%
- B/E move
- 2.2%
- Pseudo strike
- 376.71
- IV
- 46.0%
- B/E move
- 1.6%
75Δ
- Pseudo strike
- 334.01
- IV
- 46.2%
- B/E move
- 1.8%
- Pseudo strike
- 382.42
- IV
- 46.1%
- B/E move
- 1.2%
80Δ
- Pseudo strike
- 328.87
- IV
- 45.6%
- B/E move
- 1.3%
- Pseudo strike
- 388.68
- IV
- 46.0%
- B/E move
- 0.9%
Options history
Table
| Date | IV (%) |
|---|---|
| 38.05% | |
| 36.30% | |
| 36.00% | |
| 37.29% | |
| 37.46% | |
| 38.19% | |
| 38.16% | |
| 38.49% | |
| 38.63% | |
| 40.88% |
Biotechnology
ORIC
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of cancers. The company is headquartered in South San…
More →ORKA
Oruka Therapeutics, Inc. is a biotechnology company.
More →ORMP
Oramed Pharmaceuticals Inc. is dedicated to the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or…
More →OTLK
Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. The company…
More →OVID
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medications for patients and families with neurological disorders in the United States. The company is…
More →PBLS
Parabilis Medicines, Inc. (Ticker: PBLS) is an emerging company at the forefront of the telecommunications sector, dedicated to delivering innovative communication solutions…
More →